Home
Intas Pharmaceuticals

Intas Pharmaceuticals Market Share Analysis for November 2025

Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico.

Health > Pharmacy

Domainintaspharma.com

Year Founded1976

Employees> 10001

Annual Revenue$15M - $25M

Intas Pharmaceuticals

Intas Pharmaceuticals (including company regionals)

intaspharma.com

See more website traffic and engagement information

Intas Pharmaceuticals Revenue up to November 2025 is 15M - 25M

revenue generated by Intas Pharmaceuticals top domains

Intas Pharmaceuticals top domains revenue over 3 years

Revenue for Intas Pharmaceuticals top domains

intaspharma.com15M - 25M

See more with Sales Intelligence

Total visits to Intas Pharmaceuticals's top domains

Understand Intas Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

intaspharma.com98.3K

See more with Sales Intelligence

Avg. visit duration in Intas Pharmaceuticals's top domains

Analyze Intas Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

intaspharma.com00:05:08

See more with Sales Intelligence

Avg. pageviews on Intas Pharmaceuticals's top domains

See how Intas Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

intaspharma.com4.70

See more with Sales Intelligence

Intas Pharmaceuticals top competitors by domain

Top similar sites in November 2025, ranked by their affinity

torrentpharma.comCompany NameTorrent Pharmaceuticals LimitedEmployees> 10001HQIndia, AhmedabadAnnual revenue> $1BTotal visits36KHealth > Health - Other

Top technologies used by Intas Pharmaceuticals

These are the website technologies, by industry, used by Intas Pharmaceuticals top domains

Widget (6)

Twemoji

Advertising (4)

Google Adsense

Email Services (3)

GoDaddy Email

Mobile (2)

Meta Viewport

More Technologies

7

See all

News & Signals from Intas Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIntas Pharmaceuticals Ltd hires Rohit Gupta.Intas Pharmaceuticals appoints Rohit Gupta as associate VP-HR.

NewsCoherus BioSciences, Inc. sold assets to Intas Pharmaceuticals Ltd in the amount of $558M on Dec 1st '24.Intas acquired the biosimilar drug from California-based Coherus Life Sciences in December 2024.

NewsIntas Pharmaceuticals Ltd launched HETRONIFLY on Aug 5th '25.Intas Pharmaceuticals has launched HETRONIFLY (Serplulimab), the first PD-1 inhibitor globally approved for the treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC), in the Indian market.